Publications [#259684] of Robert M. Cook-Deegan

Journal Articles

1. Zick, CD; Mathews, CJ; Roberts, JS; Cook-Deegan, R; Pokorski, RJ; Green, RC, Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior, Health Affairs, vol. 24 no. 2 (March/April 2005), pp. 483-490, ISSN 0278-2715 [doi]
   (last updated on 2016/12/04)

   Abstract:
   New genetic tests for adult-onset diseases raise concerns about possible adverse selection in insurance markets. To test for this behavior, we followed 148 cognitively normal people participating in a randomized clinical trial of genetic testing for Alzheimer's disease for one year after risk assessment and Apolipoprotein E (APOE) genotype disclosure. Although no significant differences were found in health, life, or disability insurance purchases, those who tested positive were 5.76 times more likely to have altered their long-term care insurance than those who did not receive APOE genotype disclosure. If genetic testing for Alzheimer's risk assessment becomes common, it could trigger adverse selection in long-term care insurance. © 2005 Project HOPE - The People-to-People Health Foundation, Inc.